PCED1CP

Across TCGA pan-cancer cohorts, PCED1CP RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated PCED1CP data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher PCED1CP RNA is associated with worse overall survival. In most high-consensus cancer types, elevated PCED1CP expression acts as an unfavorable survival marker, although some lineages such as HNSC and THYM show a favorable association.

ACC, KICH, and HNSC are the cancer types where PCED1CP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.100	0.838	<.001	126	view →
KICH	DFS	Tertile	All	0.372	0.922	<.001	102	view →
HNSC	OS	Tertile	IV	0.595	0.349	.016	75	view →
UCS	DFS	Tertile	All	0.138	0.530	.011	54	view →
KIRC	OS	Tertile	II,III,IV	0.337	0.586	.009	48	view →
LUAD	DFS	Tertile	IV	0.353	0.724	.036	36	view →
COAD	OS	Tertile	IV	0.089	0.676	<.001	30	view →
LIHC	OS	Tertile	II,III,IV	0.408	0.706	.040	30	view →
MESO	DFS	Tertile	III,IV	0.043	0.415	<.001	27	view →
LGG	DFS	Tertile	All	0.710	0.853	<.001	27	view →
PCPG	OS	Tertile	All	0.142	0.963	<.001	24	view →
GBM	DFS	Tertile	All	0.181	0.271	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

PCED1CP–ACC (OS)

Open the ACC breakdown →